FDA

The Dengue Vaccine Controversy Explained

The Dengue Vaccine Controversy Explained

Posted by  | Perspectives in Research

Dengue, a virus endemic to Latin America and Southeast Asia, infects about 400 million people and causes about 25,000 deaths each year by dengue hemorrhagic fever (DHF). To date there is no cure for dengue, and its toll hits hardest in areas with poorly developed medical systems. Due to the deadly consequences of this virus,(...)

More

Once-Daily Combination Pills Offer More Than Convenience

Posted by  | Perspectives in Research

In November 2015, the FDA approved the HIV-1 medication Genvoya, a once-daily pill containing fixed doses of the HIV drugs elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide. This is the latest once-daily medication to be produced to treat HIV, a disease that used to be managed primarily with many different pills taken multiple times a day.(...)

More